Free Trial
→ Is President Trump Lying To You With This? (From Colonial Metals) (Ad)
NASDAQ:NRXS

NeurAxis 8/9/2024 Earnings Report

NeurAxis logo
$2.86 +0.06 (+2.14%)
Closing price 04:00 PM Eastern
Extended Trading
$2.85 -0.01 (-0.35%)
As of 05:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
ProfileEarnings History

NeurAxis EPS Results

Actual EPS
-$0.42
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NeurAxis Revenue Results

Actual Revenue
$0.61 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NeurAxis Announcement Details

Quarter
Date
8/9/2024
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

NeurAxis Earnings Headlines

NeurAxis, Inc. Completes $5 Million Registered Direct Offering to Support Growth of IB-Stim Therapy
May 22, 2025 | quiverquant.com
NeurAxis Announces Closing of $5.0 Million Registered Direct Offering
May 22, 2025 | globenewswire.com
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.
May 29, 2025 | Colonial Metals (Ad)
NeurAxis, Inc. Announces $5 Million Stock Offering
May 22, 2025 | tipranks.com
Best Penny Stocks To Research - May 20th
May 22, 2025 | americanbankingnews.com
NeurAxis, Inc. Receives $1 Million from Warrant Exercises
May 21, 2025 | tipranks.com
See More NeurAxis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NeurAxis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeurAxis and other key companies, straight to your email.

About NeurAxis

NeurAxis (NASDAQ:NRXS), a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

View NeurAxis Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles